Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers

K. Kurz, T. Teerlink, M. Sarcletti, G. Weis, R. Zangerle, D. Fuchs

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)508-514
JournalPharmacological Research
Issue number6
Publication statusPublished - 2009

Cite this